Should I buy or sell KP Tissue stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for KP Tissue in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" KPT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KPT, but not buy additional shares or sell existing shares. View KPT analyst ratings or view top-rated stocks .

What is KP Tissue's stock price target for 2024?

3 brokerages have issued 1-year price targets for KP Tissue's stock. Their KPT share price targets range from C$9.00 to C$12.00. On average, they expect the company's stock price to reach C$9.75 in the next twelve months. This suggests a possible upside of 17.9% from the stock's current price. View analysts price targets for KPT or view top-rated stocks among Wall Street analysts .

How have KPT shares performed in 2024?

KP Tissue's stock was trading at C$9.02 on January 1st, 2024. Since then, KPT shares have decreased by 8.3% and is now trading at C$8.27. View the best growth stocks for 2024 here .

When is KP Tissue's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our KPT earnings forecast .

How were KP Tissue's earnings last quarter?

KP Tissue Inc. (TSE:KPT) announced its quarterly earnings data on Thursday, March, 7th. The company reported $0.20 EPS for the quarter, missing analysts' consensus estimates of $0.21 by $0.01. The company had revenue of $482.27 million for the quarter, compared to the consensus estimate of $498 million.

How often does KP Tissue pay dividends? What is the dividend yield for KP Tissue?

KP Tissue announced a quarterly dividend on Thursday, March 28th. Investors of record on Monday, April 15th will be given a dividend of 0.18 per share on Monday, April 15th. This represents a $0.72 dividend on an annualized basis and a yield of 8.71%. The ex-dividend date of this dividend is Thursday, March 28th. Read our dividend analysis for KPT .

Is KP Tissue a good dividend stock?

KP Tissue (TSE:KPT) pays an annual dividend of C$0.72 per share and currently has a dividend yield of 7.96%. KPT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for KPT .

What other stocks do shareholders of KP Tissue own?

Based on aggregate information from My MarketBeat watchlists, some companies that other KP Tissue investors own include Intact Financial (IFC) , Constellation Software (CSU) , AutoCanada (ACQ) , Alimentation Couche-Tard (ATD.B) , AbbVie (ABBV) , Vermilion Energy (VET) , Wheaton Precious Metals (WPM) , Open Text (OTEX) , Rogers Communications (RCI) and Valeant Pharmaceuticals International (VRX) .

How do I buy shares of KP Tissue?

Shares of KPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

TSE:KPT

KP Tissue (KPT) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free KPT Stock Alerts

C$8.27

-0.02 (-0.24%)

(As of 04/18/2024 ET)

Compare

Today's Range: C$8.27
▼
C$8.88
50-Day Range: C$8.24
▼
C$9.05
52-Week Range: C$8.20
▼
C$10.84

Volume: 11,814 shs
Average Volume: 19,096 shs
Market Capitalization: C$82.37 million

P/E Ratio: N/A
Dividend Yield: 8.71%
Price Target: C$9.75

Stock Analysis Analyst Forecasts Chart Competitors Dividend Earnings Headlines Insider Trades

Get KP Tissue alerts:

KP Tissue MarketRank™ Stock Analysis

Analyst Rating: Hold
2.33 Rating Score
Upside/Downside: 17.9% Upside
C$9.75 Price Target
Short Interest: N/A
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: -0.75
Based on 2 Articles This Week
Insider Trading: Acquiring Shares
C$1,338 Bought Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.42 out of 5 stars

2.2

Analyst's Opinion

Consensus Rating
KP Tissue has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.
Amount of Analyst Coverage
KP Tissue has only been the subject of 1 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for KPT.

1.7

Dividend Strength

Dividend Leadership
KP Tissue is a leading dividend payer. It pays a dividend yield of 7.96%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
KP Tissue does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for KPT.

0.7

News and Social Media Coverage

News Sentiment
KP Tissue has a news sentiment score of -0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.34 average news sentiment score of Consumer Defensive companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for KP Tissue this week, compared to 0 articles on an average week.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, KP Tissue insiders have bought more of their company's stock than they have sold. Specifically, they have bought C$1,338.00 in company stock and sold C$0.00 in company stock.
Percentage Held by Insiders
Only 0.14% of the stock of KP Tissue is held by insiders.
Percentage Held by Institutions
Only 13.32% of the stock of KP Tissue is held by institutions.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of KP Tissue is -16.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of KP Tissue is -16.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Due to a projected decrease in earnings for KP Tissue, their PEG ratio cannot be calculated.
Price to Book Value per Share Ratio
KP Tissue has a P/B Ratio of 1.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About KP Tissue Stock (TSE:KPT)

KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under the Cashmere, SpongeTowels, Scotties, Purex, Bonterra, Purex, Metro, White Swan, Embassy, and Chalet brand names, as well as under private labels. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.

KPT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

KPT Stock News Headlines

April 17, 2024 | americanbankingnews.com

KP Tissue (TSE:KPT) Price Target Cut to C$9.00 by Analysts at TD Securities

March 14, 2024 | theglobeandmail.com

It’s 1995, with big gains ahead, not 1999 says prominent U.S. market strategist

April 18, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

March 12, 2024 | theglobeandmail.com

CEO of KP Tissue continues to add assets, manage risks of pulp prices

March 7, 2024 | msn.com

KP Tissue GAAP EPS of C$0.20, revenue of C$482.3M; initiates Q1 outlook

March 5, 2024 | finance.yahoo.com

KRUGER PRODUCTS ANNOUNCES MAJOR INCREASE IN ITS FACIAL TISSUE PRODUCTION CAPACITY WITH AN INVESTMENT OF $14.5 MILLION

February 22, 2024 | morningstar.com

KP Tissue Inc KPT

February 17, 2024 | investing.com

KP Tissue Inc (KPT)

April 18, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

February 7, 2024 | finance.yahoo.com

KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Fourth Quarter of 2023

January 31, 2024 | ca.finance.yahoo.com

KP Tissue Inc. (KPT.TO)

November 8, 2023 | finanznachrichten.de

KP Tissue Inc.: KP Tissue Releases Third Quarter 2023 Financial Results

October 9, 2023 | finance.yahoo.com

KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Third Quarter of 2023

October 7, 2023 | theglobeandmail.com

Closing Bell: Kp Tissue Inc flat on Friday (KPT)

September 29, 2023 | finance.yahoo.com

Unraveling the Dividend Saga of KP Tissue Inc (KPTSF)

August 29, 2023 | finance.yahoo.com

KP Tissue's (TSE:KPT) Dividend Will Be CA$0.18

August 15, 2023 | theglobeandmail.com

Closing Bell: Kp Tissue Inc down on Monday (KPT)

August 10, 2023 | finance.yahoo.com

KP Tissue Releases Second Quarter 2023 Financial Results

July 17, 2023 | msn.com

Innovation and Adaptation: KP Tissue Ensures Consistency amidst Decreased Performance

July 10, 2023 | finance.yahoo.com

KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Second Quarter of 2023

May 12, 2023 | msn.com

KP Tissue (KPTSF) Declares $0.18 Dividend

May 11, 2023 | finanznachrichten.de

KP Tissue Inc.: KP Tissue Releases First Quarter 2023 Financial Results

May 11, 2023 | marketwatch.com

REMINDER - KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the First Quarter of 2023

May 11, 2023 | finance.yahoo.com

KP Tissue Releases First Quarter 2023 Financial Results

May 10, 2023 | finance.yahoo.com

REMINDER – KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the First Quarter of 2023

April 29, 2023 | theglobeandmail.com

Closing Bell: Kp Tissue Inc down on Friday (KPT)

April 27, 2023 | theglobeandmail.com

Closing Bell: Kp Tissue Inc up on Wednesday (KPT)

See More Headlines

Receive KPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KP Tissue and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/07/2024
Ex-Dividend for 4/15 Dividend: 3/28/2024
Dividend Payable: 4/15/2024
Today: 4/18/2024
Next Earnings (Confirmed): 5/14/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Sector: Consumer Defensive
Industry: Household & Personal Products
Sub-Industry: N/A
Current Symbol: TSE:KPT
CUSIP: N/A
CIK: N/A
Web: kptissueinc.com
Phone: +1-905-8126900
Fax: N/A
Employees: N/A
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: C$9.75
High Stock Price Target: C$12.00
Low Stock Price Target: C$9.00
Potential Upside/Downside: +17.3%
Consensus Rating: Hold
Rating Score (0-4): 2.33
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): C($0.50)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 17.22
P/E Growth: -0.88
Net Income: C$-4,940,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -6.93%
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.09
Quick Ratio: 1.23

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: C$6.86 per share
Price / Book: 1.21

Miscellaneous

Outstanding Shares: 9,960,000
Free Float: N/A
Market Cap: C$82.77 million
Optionable: Not Optionable
Beta: 0.35

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. Dino J. Bianco (Age 62)
Chief Executive Officer
Comp: $737.68k
Mr. Michel Manseau
Senior VP & GM of Consumer Business Canada - Kruger Products LP
Mr. Gordon Goss
Senior VP and GM of Consumer Business USA & Mexico - Kruger Products LP
Mr. Michael Keays
Chief Financial Officer
Mr. Marc James Fitzgerald
Corporate Vice President of Technology & Product Development - Kruger Products LP
Mike Baldesarra CPA
CA, Director of Investor Relations
Mr. François Paroyan
SVP of General Counsel & Corporate Affairs and Corporate Secretary
Mr. Rob Latter
Senior VP & GM of Away from Home Business - Kruger Products LP
Ms. Nancy Marcus
Chief Marketing Officer of Kruger Products LP
Ms. Susan Irving
Chief Marketing Officer of KPLP

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

KPT Stock Analysis - Frequently Asked Questions

Should I buy or sell KP Tissue stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for KP Tissue in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" KPT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KPT, but not buy additional shares or sell existing shares.
View KPT analyst ratings or view top-rated stocks.
What is KP Tissue's stock price target for 2024?: 3 brokerages have issued 1-year price targets for KP Tissue's stock. Their KPT share price targets range from C$9.00 to C$12.00. On average, they expect the company's stock price to reach C$9.75 in the next twelve months. This suggests a possible upside of 17.9% from the stock's current price.
View analysts price targets for KPT or view top-rated stocks among Wall Street analysts.
How have KPT shares performed in 2024?: KP Tissue's stock was trading at C$9.02 on January 1st, 2024. Since then, KPT shares have decreased by 8.3% and is now trading at C$8.27.
View the best growth stocks for 2024 here.
When is KP Tissue's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our KPT earnings forecast.
How were KP Tissue's earnings last quarter?: KP Tissue Inc. (TSE:KPT) announced its quarterly earnings data on Thursday, March, 7th. The company reported $0.20 EPS for the quarter, missing analysts' consensus estimates of $0.21 by $0.01. The company had revenue of $482.27 million for the quarter, compared to the consensus estimate of $498 million.

How often does KP Tissue pay dividends? What is the dividend yield for KP Tissue?: KP Tissue announced a quarterly dividend on Thursday, March 28th. Investors of record on Monday, April 15th will be given a dividend of 0.18 per share on Monday, April 15th. This represents a $0.72 dividend on an annualized basis and a yield of 8.71%. The ex-dividend date of this dividend is Thursday, March 28th.
Read our dividend analysis for KPT.
Is KP Tissue a good dividend stock?: KP Tissue (TSE:KPT) pays an annual dividend of C$0.72 per share and currently has a dividend yield of 7.96%. KPT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for KPT.
What other stocks do shareholders of KP Tissue own?: Based on aggregate information from My MarketBeat watchlists, some companies that other KP Tissue investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Open Text (OTEX), Rogers Communications (RCI) and Valeant Pharmaceuticals International (VRX).
How do I buy shares of KP Tissue?: Shares of KPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:KPT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

KP Tissue (KPT) Stock Price, News & Analysis

KP Tissue MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Company Ownership

Earnings and Valuation

About KP Tissue Stock (TSE:KPT)

KPT Stock Price History

KPT Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

KPT Stock Analysis - Frequently Asked Questions

Overall MarketRank^™